Home > Items where Subject is "B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 118.


Bozinoff, Nikki and Tardelli, Vitor and Rubin-Kahana, Dafna Sara and Le Foll, Bernard (2022) Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm Reduction Journal , 19 .

Frost, Madeline C and Zhang, Lan and Kim, H Myra and Lin, Lewei Allison (2022) Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. JAMA Network Open , 5 , (10) .

Bozinoff, Nikki and Men, Siyu and Kurdyak, Paul and Selby, Peter and Gomes, Tara (2022) Prescribing characteristics associated with opioid overdose following buprenorphine taper. JAMA Network Open , 5 , (9) .

Krawczyk, Noa and Allen, Sean T and Schneider, Kristin E and Solomon, Keisha and Shah, Hridika and Morris, Miles and Harris, Samantha J and Sherman, Susan G and Saloner, Brendan (2022) Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs. Harm Reduction Journal , 19 .

Glanz, Jason M and Binswanger, Ingrid A and Clarke, Christina L and Nguyen, Anh P and Ford, Morgan A and Ray, G Thomas and Xu, Stanley and Hechter, Rulin C and Yarborough, Bobbi Jo H and Roblin, Douglas W and Ahmedani, Brian and Boscarino, Joseph A and Andrade, Susan E and Rosa, Carmen L and Campbell, Cynthia I (2022) The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction , Early online . (In Press)

Heikkinen, Milja and Taipale, Heidi and Tanskanen, Antti and Mittendorfer-Rutz, Ellenor and Lähteenvuo, Markku and Tiihonen, Jari (2022) Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction , 117 , (6) , pp. 1683-1691.

O'Reilly, Daniel and McCartan, Frances and Rizvi, Syed (2022) An unusual case of buprenorphine overdose secondary to sibling play: examining how medication delivery devices appear to children. British Journal of Clinical Pharmacology , 88 , (6) , pp. 2996-2997.

Ward, Kathleen M and Scheim, Ayden and Wang, Jonathan and Cocchiaro, Benjamin and Singley, Katie and Roth, Alexis M (2022) Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program. Drug and Alcohol Dependence Reports , 3 .

Xu, Kevin Y and Mintz, Carrie M and Presnall, Ned and Bierut, Laura J and Grucza, Richard A (2022) Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use. JAMA Network Open , 5 , (5) .

Mintz, Carrie M and Xu, Kevin Y and Presnall, Ned J and Hartz, Sarah M and Levin, Frances R and Scherrer, Jeffrey F and Bierut, Laura J and Grucza, Richard A (2022) Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder. JAMA Network Open , 5 , (5) .

Matheson, Catriona and Foster, Rebecca and Schofield, Joe and Browne, Tania (2022) Long-acting depot buprenorphine in people who are homeless: views and experiences. Journal of Substance Abuse Treatment .

Ghanem, Nessreen and Dromgoole, Devin and Hussein, Ahmad and Jermyn, Richard T (2022) Review of medication-assisted treatment for opioid use disorder. Journal of Osteopathic Medicine .

Moriarty, Frank and Bennett, Kathleen and Fahey, Tom (2022) Opioid and analgesic utilization in Ireland in 2000 and 2015: a repeated cross-sectional study. Pharmacology Research & Perspectives , 10 , (1) , e00899.

Dunlop, Adrian J and White, Bethany and Roberts, Jillian and Cretikos, Michelle and Attalla, Dena and Ling, Rod and Searles, Andrew and Mackson, Judith and Doyle, Michael F and McEntyre, Elizabeth and Attia, John and Oldmeadow, Christopher and Howard, Mark V and Murrell, Terry and Haber, Paul Steven and Lintzeris, Nicholas (2022) Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction , 117 , (2) , pp. 382-391.

Farrell, Michael and Shahbazi, Jeyran and Byrne, Marianne and Grebely, Jason and Lintzeris, Nicholas and Chambers, Mark and Larance, Briony and Ali, Robert and Nielsen, Suzanne and Dunlop, Adrian and Dore, Gregory J and McDonough, Michael and Montebello, Mark and Nicholas, Thomas and Weiss, Rob and Rodgers, Craig and Cook, Jon and Degenhardt, Louisa (2021) Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. International Journal on Drug Policy , 100 , p. 103492.

Kohan, Lynn and Potru, Sudheer and Barreveld, Antje M and Sprintz, Michael and Lane, Olabisi and Aryal, Anuj and Emerick, Trent and Dopp, Anna and Chhay, Sophia and Viscusi, Eugene (2021) Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Regional Anesthesia and Pain Medicine , 46 , (10) , pp. 840-859.

Elarabi, Hesham Farouk and Shawky, Mansour and Mustafa, Nael and Radwan, Doaa and Elarasheed, Abuelgasim and Yousif Ali, Ahmed and Osman, Mona and Kashmar, Ahmed and Al Kathiri, Helal and Gawad, Tarek and Kodera, Ayman and Al Jneibi, Mohammed and Adem, Abdu and Lee, Amanda J and Marsden, John (2021) Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial. Addiction , 116 , (9) , pp. 2398-2408.

Barnett, Anthony and Savic, Michael and Lintzeris, Nicholas and Bathish, Ramez and Arunogiri, Shalini and Dunlop, Adrian J and Haber, Paul and Graham, Robert and Hayes, Vicky and Lubman, Dan I (2021) Tracing the affordances of long-acting injectable depot buprenorphine: a qualitative study of patients' experiences in Australia. Drug and Alcohol Dependence , 227 , p. 108959.

Klimas, Jan and Hamilton, Michee-Ana and Gorfinkel, Lauren and Adam, Ahmed and Cullen, Walter and Wood, Evan (2021) Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials. Systematic Reviews , 10 , (1) , p. 216.

Herring, Andrew A and Vosooghi, Aidan A and Luftig, Joshua and Anderson, Erik S and Zhao, Xiwen and Dziura, James and Hawk, Kathryn F and McCormack, Ryan P and Saxon, Andrew and D'Onofrio, Gail (2021) High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder. JAMA Network Open , 4 , (7) , e2117128.

Wiercigroch, David and Hoyeck, Patricia and Sheikh, Hasan and Hulme, Jennifer (2021) A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department. BMC Emergency Medicine , 21 , (1) , p. 48.

Fockele, Callan Elswick and Duber, Herbert C and Finegood, Brad and Morse, Sophie C and Whiteside, Lauren K (2021) Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington. Journal of the American College of Emergency Physicians Open , 2 , (2) , e12408.

Somers, Ciaran (2021) The case for increasing buprenorphine use as OST during Covid-19. Irish Pharmacist , February 2021 .

Santo, Thomas and Clark, Brodie and Hickman, Matt and Grebely, Jason and Campbell, Gabrielle and Sordo, Luis and Chen, Aileen and Tran, Lucy Thi and Bharat, Chrianna and Padmanathan, Prianka and Cousins, Grainne and Dupouy, Julie and Kelty, Erin and Muga, Roberto and Nosyk, Bohdan and Min, Jeong and Pavarin, Raimondo and Farrell, Michael and Degenhardt, Louisa (2021) Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry , 78 , (9) , pp. 979-993.

Medicines and Healthcare products Regulatory Agency. (2020) Opioids: risk of dependence and addiction. Drug Safety Update , 14 , (2) .

Ciapponi, Agustín (2020) Clinical question: For individuals with opiate use disorders, what are the effects of dihydrocodeine for detoxification? Cochrane Clinical Answers .

Vold, Jørn Henrik and Skurtveit, Svetlana and Aas, Christer and Chalabianloo, Fatemeh and Kloster, Pia Synnøve and Johansson, Kjell Arne and Fadnes, Lars Thore (2020) Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research , 20 , (352) , p. 352.

Wakeman, Sarah and Larochelle, Marc R and Ameli, Omid and Chaisson, Christine and McPheeters, Jeffrey Thomas and Crown, William H and Azocar, Francisca and Sanghavi, Darshak M (2020) Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open , 3 , (2: e1920622) .

Alexandridis, Apostolos A and Dasgupta, Nabarun and Ringwalt, Christopher L and Rosamond, Wayne D and Chelminski, Paul R and Marshall, Stephen W (2020) Association between opioid analgesic therapy and initiation of buprenorphine management: an analysis of prescription drug monitoring program data. PLoS ONE , 15 , (1 e0227350) , e0227350.

Clark, Brinton and Kai, Mari and Dix, Ryan and White, Jonathan and Rozenfeld, Yelena and Levy, Sheldon and Engstrom, Kathleen (2019) Association of a multimodal educational intervention for primary care physicians with prescriptions of buprenorphine for opioid use disorders. JAMA Network Open , 2 , (10) , e1913818.

Kennelly, Helen (2019) Opioid dependence: buprenorphine prolonged-release injection (Buvidal). Drugnet Ireland , Issue 70, Summer 2019 , pp. 26-27.

Strand, Maren Cecilie and Vindenes, Vigdis and Gjerde, Hallvard and Mørland, Jørg Gustav and Ramaekers, Johannes G (2019) A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers. British Journal of Clinical Pharmacology , 85 , (2) .

Drug and Alcohol Findings. (2018) Effectiveness of injectable extended-release naltrexone vs daily buprenorphine–naloxone for opioid dependence: a randomized clinical noninferiority trial. Drug and Alcohol Findings Research Analysis , (15 March 2018) .

Drug and Alcohol Findings. (2018) Drug treatment matrix cell A3: Interventions - medical treatment. Drug and Alcohol Findings Drug Treatment Matrix .

Hickman, Matthew and Steer, Colin and Tilling, Kate and Lim, Aaron G and Marsden, John and Millar, Tim and Strang, John and Telfer, Maggie and Vickerman, Peter and Macleod, John (2018) The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction , 113 , (8) .

Shanahan, Katie M and O'Grady, Michael J (2018) Advances in management of neonatal abstinence syndrome: what’s the score? Irish Medical Journal , 111 , (7) .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How does buprenorphine compare with methadone or adrenergic agonists in people undergoing opioid withdrawal? Cochrane Clinical Answers .

Galvin, Brian (2017) European drug trends 2017. Drugnet Ireland , Issue 62, Summer 2017 , pp. 1-4.

Gowing, Linda and Ali, Robert and White, Jason M (2017) Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews , (2) .

Van Hout, Marie Claire and Hearne, Evelyn and Bergin, Michael (2017) Buprenorphine-naloxone in the treatment of codeine dependence: a scoping review of clinical case presentations. International Journal of Mental Health and Addiction , 15 , (1) , pp. 224-237.

Crowley, Des and Van Hout, Marie Claire (2017) Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: a systematic review. Heroin Addiction and Related Clinical Problems , 19 , (2) .

Drug and Alcohol Findings. (2016) Worth supplementing buprenorphine with therapy? Drug and Alcohol Findings Research Analysis , (13 December 2016) .

Galvin, Brian (2016) European drug trends 2016. Drugnet Ireland , Issue 58, Summer 2016 , pp. 12-13.

O'Neill, Derek (2016) Misuse and dependence on codeine-containing medicines. Drugnet Ireland , Issue 57, Spring 2016 , pp. 16-17.

Nielsen, Suzanne and Larance, Briony and Degenhardt, Louisa and Gowing, Linda and Kehler, Chyanne and Lintzeris, Nicholas (2016) Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews , (5) .

Van Hout, Marie Claire and Delargy, Ide and Ryan, Gerry and Flanagan, Siobhan and Gallagher, Hugh (2016) Dependence on Over the Counter (OTC) codeine containing analgesics: treatment and recovery with buprenorphine naloxone. International Journal of Mental Health and Addiction , 14 , (5) , pp. 873-883.

Magalhães, Pedro V (2015) Clinical question: What are the benefits and harms of buprenorphine maintenance versus placebo or methadone maintenance in people with opioid dependence? Cochrane Clinical Answers .

Mattick, Richard P and Breen, Courtney and Kimber, Jo and Davoli, Marina (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews , (2) .

Lyons, Suzi (2013) Suboxone feasibility study evaluated. Drugnet Ireland , Issue 47, Autumn 2013 , pp. 19-22.

Lyons, Suzi (2013) Proposed regulatory framework for buprenorphine/naloxone products in Ireland. Drugnet Ireland , Issue 47, Autumn 2013 , pp. 22-23.

Drug and Alcohol Findings. (2013) Effectiveness Bank Bulletin [Effect of buprenorphine dose on treatment outcome]. Effectiveness Bank Bulletin , 15 Jul .

Drug and Alcohol Findings. (2013) Effectiveness Bank Bulletin. [Prison health care]. Effectiveness Bank Bulletin , 11 Jun .

Galvin, Brian (2013) Monitoring centre report reveals latest drug trends in Europe. Drugnet Ireland , Issue 44, Winter 2012 , pp. 4-5.

Lyons, Suzi (2012) Study findings on opiate substitution programme for adolescents. Drugnet Ireland , Issue 41, Spring 2012 , pp. 14-15.

Amass, Leslie and Pukeleviciene, Vilma and Subata, Emilis and Almeida, Antonio Rocha and Pieri, Maria Chiara Pieri and D'Egidio, Pietro and Stankova, Zdenka and Costa, Antonio and Smyth, Bobby P and Sakoman, Slavko and Wei, Yan and Strang, John (2012) A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. Addiction , 107 , (1) , pp. 142-151.

Smyth, Bobby P and Fagan, John and Kernan, Kathy (2012) Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. Journal of Substance Abuse Treatment , 42 , (1) , pp. 35-44.

Fagan, John and Keenan, Eamon (2008) Neonatal outcome following buprenorphine maintenance for opiate dependency. Irish Journal of Psychological Medicine , 25 , (4) , pp. 141-144.

Long, Jean (2007) Suboxone licensed in Europe. Drugnet Ireland , Issue 22, Summer 2007 , p. 25.

Long, Jean (2006) Buprenorphine - increasing choice for patients and doctors. Drugnet Ireland , Issue 17, Spring 2006 , pp. 19-20.

Lynn, Ena (2005) Management of Drug Users in the Primary Care Setting Conference. Drugnet Ireland , Issue 14, Summer 2005 , pp. 19-20.

O'Connor, JJ and Moloney, Eamonn and Travers, Raymond and Campbell, Aisling (1988) Buprenorphine abuse among opiate addicts. British Journal of Addiction , 83 , (9) , pp. 1085-1087.


Substance Abuse and Mental Health Services Administration. (2021) Medications for opioid use disorder. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Institut national d'excellence en sante et en services sociaux. (2021) Opioid use disorder (OUD). Opioid agonist therapy. Quebec: INESSS.

Office of the Secretary, Department of Health and Human Services. (2021) Practice guidelines for the administration of buprenorphine for treating opioid use disorder. Washington DC: Department of Health and Human Services.

International Narcotics Control Board. (2021) Narcotic drugs: estimated world requirements for 2021. New York: United Nations.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications. Technical report. Luxembourg: Publications Office of the European Union.

Substance Abuse and Mental Health Services Administration. (2020) National survey on drug use and health (NSDUH). Rockville, MD: Substance Abuse and Mental Health Services Administration.

Canadian Centre on Substance Use and Addiction. (2020) Prescription opioids: Canadian drug summary. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.

Seele, Dale W and Becker, Sara J and Danko, Kristin J and Balk, Ethan M and Saldanha, Ian J and Adam, Gaelen P and Bagley, Sarah M and Friedman, Catherine and Spirito, Anthony and Scott, Kelli and Ntzani, Evangelia E and Saeed, Iman and Smith, Bryant and Popp, Jonah and Trikalinos, Thomas A (2020) Interventions for substance use disorders in adolescents: a systematic review. Rockville, MD: Agency for Healthcare Research and Quality.

Harnedy, Norma and Kee, Jim and Cotter, Blaithin and Johnston, Helen and Egan, Mary (2020) Letter 1:. Urgent communication regarding OST patients. Dublin: Health Service Executive.

Sullivan, Tom and Voce, Isabella (2020) The social supply of pharmaceutical opioids. Canberra: Australian Institute of Criminology.

Edge, Rob and Butcher, Robyn (2019) Buprenorphine for opioid use disorders during pregnancy: a review of comparative clinical effectiveness, safety, cost-effectiveness, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health.

National Institute for Health and Care Excellence. (2019) Opioid dependence: buprenorphine prolonged release injection (Buvidal). London: NICE.

Dolan, Kate and Mehrjerdi, Zahra Alam (2015) Medication-assisted treatment of opioid dependence information toolkit. Sydney: Australian National Council on Drugs.

Gisev, Natasha and Larney, Sarah and Kimber, Jo and Burns, Lucy and Weatherburn, Don and Gibson, Amy and Dobbins, Tim and Mattick, Richard and Butler, Tony and Degenhardt, Louisa (2014) Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study. Sydney: National Drug and Alcohol Research Centre.

Canadian Agency for Drugs and Technologies in Health. (2013) Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health.

Create Consultancy. Fitzgerald, Niamh (2013) Evaluation of suboxone feasibility study in Ireland. Dublin: Department of Health.

Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. (2011) Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. Dublin: Department of Health.

(2011) Suboxone for short-term detoxification: a review of the clinical evidence. Ottowa: Canadian Agency for Drugs and Technologies in Health.

Handford, Curtis and Kahan, Meldon and Srivastava, Anita and Cirone, Sharon and Palda, Valerie (2011) Buprenorphine/Naloxone for opioid dependence: clinical practice guideline. Toronto: Centre for Addiction and Mental Health.

Health Service Executive. Social Inclusion Unit. Farrell, Michael and Barry, Joseph (2010) The introduction of the opioid treatment protocol. Dublin: Health Service Executive.

NIDA-SAMHSA Blending Initiative. (2010) Buprenorphine treatment for young adults. Bethesda, MD: NIDA-SAMHSA Blending Initiative.

NIDA-SAMHSA Blending Initiative. (2010) Short-term opioid withdrawal using buprenorphine: findings and strategies from a NIDA Clinical Trials Network (CTN) study. Bethesda, MD: NIDA-SAMHSA Blending Initiative.

Center for Substance Abuse Treatment. (2009) Buprenorphine: a guide for nurses. Rockville, MD: Substance Abuse and Mental Health Services Administration.

National Institute for Health and Clinical Excellence. (2007) Methadone and buprenorphine for the management of opioid dependence. London: NICE.

National Centre for Pharmacoeconomics. (2007) Economic evaluation of the use of Suboxone for opiate addiction. Dublin: National Centre for Pharmacoeconomics.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: selected issues. Luxembourg: Office for Official Publications of the European Communities.

Health Research Board. Drugs Misuse Research Division. (2004) 2004 National Report to the EMCDDA by the Reitox National Focal Point. Ireland. New developments, trends and in-depth information on selected issues. Dublin: Health Research Board.

RCGP Drug & Alcohol Misuse Training Programme, RCGP Sex, Drugs and HIV Task Group, SMMGP. (2004) Guidance for the use of buprenorphine for the treatment of opioid dependence in primary care. London: Royal College of General Practitioners.

Center for Substance Abuse Treatment. (2004) Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration.

McElrath, Karen (2003) Review of research on substitute prescribing for opiate dependence and implications for Northern Ireland. Belfast: Department of Health, Social Services and Public Safety.

National Medicines Information Centre. (2002) Report to the National Advisory Committee on Drugs on the use of buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome. Dublin: Stationery Office.


Organization of Teratology Information Specialists. (2022) Mother to baby: fact sheets [Internet]. Brentwood (TN): Organization of Teratology Information Specialists.

UK Teratology Information Service. (2017) BUMPS: Best use of medicines in pregnancy - Buprenorphine. London: UK Teratology Information Service.

Dail Debates

[Oireachtas] Dáil Éireann debate. Written answer 2069 – Medical products [Codeine] [44276/22] . (08 Sep 2022)

[Oireachtas] Dáil Éireann debate. Written answer 833 - Medicinal products [8145/22]. (15 Feb 2022)

[Oireachtas] Dail Eireann debate. Written answer - medicinal products data [7108/19]. (12 Feb 2019)

[Oireachtas] Dail Eireann debate. Written answer 371 - Drug treatment programmes [5593/17]. (07 Feb 2017)

[Oireachtas] Dail Eireann debate. Written answers 663, 664, 665, 666 - Drug treatment programmes [Buprenorphine-naloxone & services] [24091/16, 24092/16, 24094/16, 24093/16]. (21 Jul 2016)

[Oireachtas] Dail Eireann debate. Written answer 79 - Drug treatment programmes [Suboxone] [20967/16]. (12 Jun 2016)

[Oireachtas] Dail Eireann debate. Written answer 761 - medicinal products availability. [30578/15] [Buprenorphine]. (22 Sep 2015)

[Oireachtas] Dail Eireann debate. Priority question 5 - National drugs rehabilitation framework [27728/15]. (09 Jul 2015)

[Oireachtas] Dail Eireann debate. Written answer 376 - Medicinal products availability [19728/15] [Suboxone]. (19 May 2015)

[Oireachtas] Government's priorities for the year ahead: statements (resumed) (continued). (06 Mar 2014)

[Oireachtas] Dail Eireann debate. Written answer 205 - Drug treatment programme [Subutex] [13522/07]. (05 Apr 2007)

[Oireachtas] Dail Eireann debate. Written answer 139 - Medicinal products [Buprenorphine] [35939/06]. (02 Nov 2006)


Verster, Annette and Buning, Ernst (2005) Buprenorphine: critical questions examined. Amsterdam: Euro-Methwork .

Conference or Workshop Item

Harris, Simon (2017) Speech by Simon Harris TD , Minister for Health. In: Launch of Reducing harm, supporting recovery – A health led response to drug and alcohol use in Ireland 2017-2025., 17 July 2017, Dublin Castle.


Gupta, AK (2013) The implementation of an audit programme across drug treatment centre (DTC) pharmacies. MSc thesis, Royal College of Surgeons in Ireland.


[Medical Independent] , Lynch, David Upward trend in Suboxone prescription continues. (09 Aug 2022)

[Medical Independent] , Lynch, David Continued increase in numbers receiving Suboxone. (06 Aug 2021)

[Medical Independent] , Lynch, David HSE reaches agreement with company to allow increased access to suboxone. (04 Oct 2018)

[Evening Echo] Merchants Quay Ireland welcomes move to widen use of suboxone in drug addiction treatment. (28 Apr 2018)

[Medical Independent] , Lynch, David Negotiations for wider availability of suboxone in ‘advanced stages’. (26 Apr 2018)

[Department of Health] Misuse of Drugs (supervision of prescription and supply of methadone and medicinal products containing buprenorphine authorised for opioid substitution treatment) regulations 2017 SI No. 522 of 2017. (28 Nov 2017)

[Medical Independent] , Lynch, David A new Minister, a new policy? (09 Jun 2016)

[Irish Examiner] , Baker, Noel Methadone alternative on the cards according to HSE. (03 Jan 2016)

National Institute on Drug Abuse. [NIDA] Buprenorphine treatment in pregnancy: less distress to babies. (09 Dec 2010)

This list was generated on Fri Dec 9 04:15:45 2022 GMT.